Remarkably, the combination of EPZ-6438 and Prednisolone extends the range of cells that are sensitive to EZH2 inhibition, from the mutant bearing GCB type to include EZH2 wild-type GCB NHL cells as well. This evidence concerns the gene EZH2 and non-Hodgkin lymphoma.